A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

NCT06454630 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

179

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: REGN7508
DRUG: Enoxaparin

Sponsor

Regeneron Pharmaceuticals